Local application of e.g. anti-inflammatory and immunomodulatory drugs may be superior to systemic administration in terms of efficacy and side effects.
A depot formulation with modulated release kinetics may allow a reduction of the systemic injection frequency of subcutaneous formulations and thus help to increase patient compliance.
At the NMI, active ingredients are incorporated into coatings, capsules, foams, or hydrogels, for example, to intelligently achieve controlled and on-demand release.
A few of our focus areas: